
Home » Inovio Lands $71 Million DOD Contract for COVID-19 Vaccine Delivery Device
Inovio Lands $71 Million DOD Contract for COVID-19 Vaccine Delivery Device

Inovio Pharmaceuticals has secured a $71 million contract from the Department of Defense to scale up production of a COVID-19 vaccine delivery device.
The Cellectra 3PSP is designed to deliver the company’s vaccine candidate, INO-4800, directly into the patient’s skin.
The funding supports Inovio’s large-scale production of the devices to deliver potentially hundreds of millions of doses of its vaccine next year, the company said.
Upcoming Events
-
08Feb
-
09Feb
-
15Feb
-
16Feb
-
22Feb
-
07Mar